Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis

Arthritis and Rheumatism

Volumn 43, Issue 7, 2000, Pages 1633-1640

  Renzoni, Elisabetta ^a   Lympany, Penny ^a   Sestini, Piersante ^b   Pantelidis, Panagiotis ^a   Wells, Athol ^a   Black, Carol ^c   Welsh, Ken ^d   Bunn, Chris ^c   Knight, Chris ^c   Foley, Patrick ^a   Du Bois, R M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF SIENA   (Italy)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; DNA; DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FIBROSING ALVEOLITIS; GENE FREQUENCY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ANTIGENS, CD; DNA; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PULMONARY FIBROSIS; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; SCLERODERMA, SYSTEMIC;

EID: 0033923117     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200007)43:7<1633::AID-ANR29>3.0.CO;2-9     Document Type: Article

References (43)

1. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991;9:617-48.
2. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989;143:1366-71.
3. Morris SW, Nelson N, Valentine MB, Shapiro DN, Look AT, Kozlosky CJ, et al. Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35. Genomics 1992;14:685-91.
4. Sprenger H, Lloyd AR, Lautens LL, Bonner TI, Kelvin DJ. Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem 1994;269:11065-72.
5. Ahuja SK, Shetty A, Tiffany HL, Murphy P. Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B. J Biol Chem 1994;269:26381-9.
6. Briggs DC, Vaughan RW, Welsh KI, Myers A, du Bois RM, Black CM. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 1991;338:661-2.
7. Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 1999; 20:106-12.
8. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members. N Engl J Med 1986;314:1343-7.
9. Musk AW, Zilko PJ, Manners P, Kay PH, Kamhoh MI. Genetic studies in familial fibrosing alvcolitis: possible linkage with immunoglobulin allotypes (Gm). Chest 1986;89:206-10.
10. Haston CK, Amos CI, King TM, Travis EL. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res 1996;56:2596-601.
11. El-Gamel A, Awad MR, Hasleton PS, Yonan NA, Hutchinson JA, Campbell GS. Transforming growth factor-beta genotype and lung allograft fibrosis. J Heart Lung Transplant 1999;18:517-23.
12. Ogushi F, Tani K, Maniwa K, Ichikawa W, Tada H, Kawano T, et al. Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis. J Med Invest 1997;44:53-8.
13. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 1997;40:743-51.
14. Southcott AM, Jones KP, Li D, Majumdar S, Cambrey AD, Pantelidis P, et al. Interleukin-8: differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995;151:604-12.
15. Watters LC, Schwartz MI, Cherniak RM. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships to lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987;135:696-704.
16. Cantin AM, North SL, Fells GA, Hubbard M, Crystal RG. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987;79:1665-73.
17. Crestani B, Seta N, Palazzo E, Rolland C, Venembre P, Dehoux M, et al. Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;150:1363-7.
18. Lynch JP III, Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992;145:1433-9.
19. Strieter RM, Koch AE, Antony VB, Fick RB, Standiford TJ, Kunkel SK. The immunopathology of chemotactic chemokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 1994;123:183-97.
20. Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, et al. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 1999;162:5511-8.
21. Subcommittee for Scleroderma Criteria of the American Rheumatism Committee Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
22. LeRoy EC, Black C, Fleishmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
23. Bunce M, O'Neill CM, Barnardo MC, Kransa P, Browning MJ, Morris PJ, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
24. Miller SA, Dykes SS, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
25. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 1997;50:23-31.
26. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 1998;15: 173-81.
27. Fey MF, Tobler A. An interleukin-8 (IL-8) cDNA clone identifies a frequent HindIII polymorphism. Hum Genet 1992;91:298.
28. Emi M, Keicho N, Tokunaga K, Katsumata H, Souma S, Nakata K, et al. Association of diffuse panbronchiolitis with microsatellite polymorphism of the human interleukin 8 (IL-8) gene. J Hum Genet 1999;44:169-72.
29. White JK, Shaw MA, Barton CH, Cerretti DP, Williams H, Mock BA, et al. Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP. Genomics 1994;24: 295-302.
30. Santamaria Babi LF, Moser B, Perez Soler MT, Moser R, Loctscher P, Villiger B, et al. The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells. Eur J Immunol 1996;26:2056-61.
31. Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis: quantitation, subtyping, and clinical correlations. Arthritis Rheum 1984;27:645-53.
32. Hawkins RA, Claman HN, Clark RAG, Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 1985;102:182-6.
33. Seibold JR, Giorno RC, Claman HN. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990;33:1702-9.
34. Nilsson G, Mikovits JA, Metcalfe DD, Taub DD. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/interleukin-8RB. Blood 1999;93:2791-7.
35. Stricter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270: 27348-57.
36. Stricter RM, Kunkel SL, Elner VM, Martonyl CL, Koch AE, Polverini PJ, et al. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992;141:1279-84.
37. Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res 1998;18:77-81.
38. Murdoch C, Monk PN, Finn A. CXC chemokine receptor expression on human endothelial cells. Cytokine 1999;11:704-12.
39. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983;1:195-205.
40. Maricq HR, Weinberger AB, LeRoy EC. Early detection of scleroderma spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. J Rheumatol 1982;9:289-91.
41. Beaulieu AD, McColl SR. Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 1994;37:855-9.
42. Konig A, Krenn V, Gillizter R, Glockner J, Janssen E, Gohlke F. Inflammatory infiltrate and interleukin-8 expression in the synovium of psoriatic arthritis - an immunohistochemical and mRNA analysis. Rheumatol Int 1997;17:159-68.
43. Goodman RB, Strieter RM, Martin DM, Steinberg KB, Milberg JA, Maunder RJ, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-11.